{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:42:55Z","timestamp":1790617375129,"version":"4.1.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-022-05602-z","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T08:04:33Z","timestamp":1646640273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of treatments for neurotrophic keratopathy: a systematic review and meta-analysis"],"prefix":"10.1007","author":[{"given":"S\u00e9bastien","family":"Roumeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Dutheil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien S.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Chiambaretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6317-345X","authenticated-orcid":false,"given":"Valentin","family":"Navel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"issue":"19","key":"5602_CR1","doi-asserted-by":"publisher","first-page":"30400","DOI":"10.1016\/j.jtos.2019.11.008","volume":"S1542\u20130124","author":"S Saad","year":"2019","unstructured":"Saad S, Abdelmassih Y, Saad R et al (2019) Neurotrophic keratitis: frequency, etiologies, clinical management and outcomes. Ocul Surf S1542\u20130124(19):30400\u201330408. https:\/\/doi.org\/10.1016\/j.jtos.2019.11.008","journal-title":"Ocul Surf"},{"key":"5602_CR2","doi-asserted-by":"publisher","unstructured":"S Bonini P Rama D Olzi A Lambiase 2003Neurotrophic keratitis Eye Lond Engl 17 989 995 https:\/\/doi.org\/10.1038\/sj.eye.6700616","DOI":"10.1038\/sj.eye.6700616"},{"key":"5602_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2018.04.003","volume":"66","author":"HS Dua","year":"2018","unstructured":"Dua HS, Said DG, Messmer EM et al (2018) Neurotrophic keratopathy. Prog Retin Eye Res 66:107\u2013131. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.04.003","journal-title":"Prog Retin Eye Res"},{"key":"5602_CR4","unstructured":"L You FE Kruse HE Volcker 2000 Neurotrophic factors in the human cornea 41 11"},{"key":"5602_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/s0014-4835(03)00050-2","volume":"76","author":"LJ M\u00fcller","year":"2003","unstructured":"M\u00fcller LJ, Marfurt CF, Kruse F, Tervo TMT (2003) Corneal nerves: structure, contents and function. Exp Eye Res 76:521\u2013542. https:\/\/doi.org\/10.1016\/s0014-4835(03)00050-2","journal-title":"Exp Eye Res"},{"key":"5602_CR6","doi-asserted-by":"publisher","unstructured":"Ruiz-Lozano RE, Hernandez-Camarena JC, Loya-Garcia D, et al (2020) The molecular basis of neurotrophic keratopathy: diagnostic and therapeutic implications. A review. Ocul Surf. https:\/\/doi.org\/10.1016\/j.jtos.2020.09.007","DOI":"10.1016\/j.jtos.2020.09.007"},{"key":"5602_CR7","first-page":"452","volume-title":"Current ocular therapy","author":"IA Mackie","year":"1995","unstructured":"Mackie IA (1995) Neuroparalytic keratitis. In: Fraunfelder FT, Roy FH, Grove J (eds) Current ocular therapy, 4th edn. W. B. Saunders, Philadelphia, pp 452\u2013454","edition":"4"},{"key":"5602_CR8","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","volume":"29","author":"C Baudouin","year":"2010","unstructured":"Baudouin C, Labb\u00e9 A, Liang H et al (2010) Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 29:312\u2013334. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.03.001","journal-title":"Prog Retin Eye Res"},{"key":"5602_CR9","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1167\/iovs.11-8775","volume":"53","author":"J Sarkar","year":"2012","unstructured":"Sarkar J, Chaudhary S, Namavari A et al (2012) Corneal neurotoxicity due to topical benzalkonium chloride. Investig Opthalmology Vis Sci 53:1792. https:\/\/doi.org\/10.1167\/iovs.11-8775","journal-title":"Investig Opthalmology Vis Sci"},{"key":"5602_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/IOP.0000000000001583","volume":"36","author":"JK Park","year":"2020","unstructured":"Park JK, Charlson ES, Leyngold I, Kossler AL (2020) Corneal neurotization: a review of pathophysiology and outcomes. Ophthal Plast Reconstr Surg 36:431\u2013437. https:\/\/doi.org\/10.1097\/IOP.0000000000001583","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"5602_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40265-020-01289-w","volume":"80","author":"ED Deeks","year":"2020","unstructured":"Deeks ED, Lamb YN (2020) Cenegermin: a review in neurotrophic keratitis. Drugs 80:489\u2013494. https:\/\/doi.org\/10.1007\/s40265-020-01289-w","journal-title":"Drugs"},{"key":"5602_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.jtos.2019.09.002","volume":"17","author":"A Di Zazzo","year":"2019","unstructured":"Di Zazzo A, Coassin M, Varacalli G et al (2019) Neurotrophic keratopathy: pros and cons of current treatments. Ocul Surf 17:619\u2013623. https:\/\/doi.org\/10.1016\/j.jtos.2019.09.002","journal-title":"Ocul Surf"},{"key":"5602_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/EB.S117261","volume":"10","author":"P Versura","year":"2018","unstructured":"Versura P, Giannaccare G, Pellegrini M et al (2018) Neurotrophic keratitis: current challenges and future prospects. Eye Brain 10:37\u201345. https:\/\/doi.org\/10.2147\/EB.S117261","journal-title":"Eye Brain"},{"key":"5602_CR14","doi-asserted-by":"publisher","unstructured":"A Lambiase M Sacchetti 2014 Diagnosis and management of neurotrophic keratitis ClinOphthalmol 571 https:\/\/doi.org\/10.2147\/OPTH.S45921","DOI":"10.2147\/OPTH.S45921"},{"key":"5602_CR15","doi-asserted-by":"publisher","unstructured":"ES Ong BH Jeng 2021 Current and future therapies for persistent corneal epithelial defects and neurotrophickeratopathy Curr Opin Ophthalmol https:\/\/doi.org\/10.1097\/ICU.0000000000000749","DOI":"10.1097\/ICU.0000000000000749"},{"key":"5602_CR16","doi-asserted-by":"publisher","unstructured":"TH Dohlman RB Singh R Dana 2021 Advances in the medical management of neurotrophic keratitis SeminOphthalmol 1\u20136 https:\/\/doi.org\/10.1080\/08820538.2021.1900282","DOI":"10.1080\/08820538.2021.1900282"},{"key":"5602_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jtos.2020.11.003","volume":"19","author":"T Trinh","year":"2021","unstructured":"Trinh T, Santaella G, Mimouni M et al (2021) Assessment of response to multimodal management of neurotrophic corneal disease. Ocul Surf 19:330\u2013335. https:\/\/doi.org\/10.1016\/j.jtos.2020.11.003","journal-title":"Ocul Surf"},{"key":"5602_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/ICL.0000000000000774","volume":"47","author":"TP Margolis","year":"2021","unstructured":"Margolis TP (2021) Neurotrophic keratopathy: ophthalmology\u2019s diabetic foot problem. Eye Contact Lens 47:136\u2013139. https:\/\/doi.org\/10.1097\/ICL.0000000000000774","journal-title":"Eye Contact Lens"},{"key":"5602_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4997\/JRCPE.2011.209","volume":"41","author":"R Harbour","year":"2011","unstructured":"Harbour R, Lowe G, Twaddle S (2011) Scottish Intercollegiate Guidelines Network: the first 15 years (1993\u20132008). J R Coll Physicians Edinb 41:163\u2013168. https:\/\/doi.org\/10.4997\/JRCPE.2011.209","journal-title":"J R Coll Physicians Edinb"},{"key":"5602_CR20","doi-asserted-by":"publisher","first-page":"e000048","DOI":"10.1136\/bmjopen-2010-000048","volume":"1","author":"BR da Costa","year":"2011","unstructured":"da Costa BR, Cevallos M, Altman DG et al (2011) Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 1:e000048\u2013e000048. https:\/\/doi.org\/10.1136\/bmjopen-2010-000048","journal-title":"BMJ Open"},{"key":"5602_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jclinepi.2020.06.015","volume":"126","author":"S Minozzi","year":"2020","unstructured":"Minozzi S, Cinquini M, Gianola S et al (2020) The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application. J Clin Epidemiol 126:37\u201344. https:\/\/doi.org\/10.1016\/j.jclinepi.2020.06.015","journal-title":"J Clin Epidemiol"},{"key":"5602_CR22","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"5602_CR23","doi-asserted-by":"publisher","unstructured":"(2007) Probing STROBE: epidemiology 18:789\u2013790. https:\/\/doi.org\/10.1097\/EDE.0b013e318157752d","DOI":"10.1097\/EDE.0b013e318157752d"},{"key":"5602_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156431","volume":"11","author":"C Benoist d\u2019Azy","year":"2016","unstructured":"Benoist d\u2019Azy C, Pereira B, Naughton G et al (2016) Antibioprophylaxis in prevention of endophthalmitis in intravitreal injection: a systematic review and meta-analysis. PLoS ONE 11:e0156431. https:\/\/doi.org\/10.1371\/journal.pone.0156431","journal-title":"PLoS ONE"},{"key":"5602_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009675","volume":"6","author":"R Courtin","year":"2016","unstructured":"Courtin R, Pereira B, Naughton G et al (2016) Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis. BMJ Open 6:e009675. https:\/\/doi.org\/10.1136\/bmjopen-2015-009675","journal-title":"BMJ Open"},{"key":"5602_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jtos.2019.06.004","volume":"17","author":"V Navel","year":"2019","unstructured":"Navel V, Mulliez A, Benoist d\u2019Azy C et al (2019) Efficacy of treatments for Demodex blepharitis: a systematic review and meta-analysis. Ocul Surf 17:655\u2013669. https:\/\/doi.org\/10.1016\/j.jtos.2019.06.004","journal-title":"Ocul Surf"},{"key":"5602_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0896-1549(03)00013-0","volume":"16","author":"C Kniestedt","year":"2003","unstructured":"Kniestedt C, Stamper R (2003) Visual acuity and its measurement. Ophthalmol Clin N Am 16:155\u2013170. https:\/\/doi.org\/10.1016\/S0896-1549(03)00013-0","journal-title":"Ophthalmol Clin N Am"},{"key":"5602_CR28","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/ijcp.12435","volume":"68","author":"L Citrome","year":"2014","unstructured":"Citrome L (2014) Paging Dr Cohen, Paging Dr Cohen\u2026An effect size interpretation is required STAT!: visualising effect size and an interview with Kristoffer Magnusson. Int J Clin Pract 68:533\u2013534. https:\/\/doi.org\/10.1111\/ijcp.12435","journal-title":"Int J Clin Pract"},{"key":"5602_CR29","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.ophtha.2018.02.022","volume":"125","author":"S Bonini","year":"2018","unstructured":"Bonini S, Lambiase A, Rama P et al (2018) Phase II randomized, double-masked, vehicle-controlled trial of recombinant human nerve growth factor for neurotrophic keratitis. Ophthalmology 125:1332\u20131343. https:\/\/doi.org\/10.1016\/j.ophtha.2018.02.022","journal-title":"Ophthalmology"},{"key":"5602_CR30","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0161-6420(00)00163-9","volume":"107","author":"S Bonini","year":"2000","unstructured":"Bonini S (2000) Topical treatment with nerve growth factor for neurotrophic keratitis. Ophthalmology 107:1347\u20131351. https:\/\/doi.org\/10.1016\/S0161-6420(00)00163-9","journal-title":"Ophthalmology"},{"key":"5602_CR31","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/bjophthalmol-2018-313042","volume":"103","author":"J Catapano","year":"2019","unstructured":"Catapano J, Fung SSM, Halliday W et al (2019) Treatment of neurotrophic keratopathy with minimally invasive corneal neurotisation: long-term clinical outcomes and evidence of corneal reinnervation. Br J Ophthalmol 103:1724\u20131731. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313042","journal-title":"Br J Ophthalmol"},{"key":"5602_CR32","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1136\/bjo.84.8.826","volume":"84","author":"HJ Chen","year":"2000","unstructured":"Chen HJ, Pires RT, Tseng SC (2000) Amniotic membrane transplantation for severe neurotrophic corneal ulcers. Br J Ophthalmol 84:826\u2013833. https:\/\/doi.org\/10.1136\/bjo.84.8.826","journal-title":"Br J Ophthalmol"},{"key":"5602_CR33","doi-asserted-by":"publisher","unstructured":"P Fogagnolo G Giannaccare F Bolognesi et al 2020 Direct versus indirect corneal neurotization for the treatment of neurotrophickeratopahty: a multicenter prospective comparative study Am J Ophthalmol S0002939420303408 https:\/\/doi.org\/10.1016\/j.ajo.2020.07.003","DOI":"10.1016\/j.ajo.2020.07.003"},{"key":"5602_CR34","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0041-1345(03)00699-7","volume":"35","author":"O Gris","year":"2003","unstructured":"Gris O, L\u00f3pez-Navidad A, Caballero F et al (2003) Amniotic membrane transplantation for ocular surface pathology: long-term results. Transplant Proc 35:2031\u20132035. https:\/\/doi.org\/10.1016\/S0041-1345(03)00699-7","journal-title":"Transplant Proc"},{"key":"5602_CR35","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.oftale.2013.09.017","volume":"88","author":"AM Guadilla","year":"2013","unstructured":"Guadilla AM, Balado P, Baeza A, Merino M (2013) Effectiveness of topical autologous serum treatment in neurotrophic keratopathy. Arch Soc Esp Oftalmol Engl Ed 88:302\u2013306. https:\/\/doi.org\/10.1016\/j.oftale.2013.09.017","journal-title":"Arch Soc Esp Oftalmol Engl Ed"},{"key":"5602_CR36","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/01.ico.0000151547.08113.d1","volume":"24","author":"S Hick","year":"2005","unstructured":"Hick S, Demers PE, Brunette I et al (2005) Amniotic membrane transplantation and fibrin glue in the management of corneal ulcers and perforations: a review of 33 cases. Cornea 24:369\u2013377. https:\/\/doi.org\/10.1097\/01.ico.0000151547.08113.d1","journal-title":"Cornea"},{"key":"5602_CR37","first-page":"47","volume":"26","author":"B Ivekovi\u0107","year":"2002","unstructured":"Ivekovi\u0107 B, Tedeschi-Reiner E, Petric I et al (2002) Amniotic membrane transplantation for ocular surface reconstruction in neurotrophic corneal ulcera. Coll Antropol 26:47\u201354","journal-title":"Coll Antropol"},{"key":"5602_CR38","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1097\/ICO.0b013e3181a2a7f6","volume":"28","author":"BH Jeng","year":"2009","unstructured":"Jeng BH, Dupps WJ Jr (2009) Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Cornea 28:1104\u20131108. https:\/\/doi.org\/10.1097\/ICO.0b013e3181a2a7f6","journal-title":"Cornea"},{"key":"5602_CR39","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/01.ico.0000153102.19776.80","volume":"24","author":"S Khokhar","year":"2005","unstructured":"Khokhar S, Natung T, Sony P et al (2005) Amniotic membrane transplantation in refractory neurotrophic corneal ulcers: a randomized, controlled clinical trial. Cornea 24:654\u2013660. https:\/\/doi.org\/10.1097\/01.ico.0000153102.19776.80","journal-title":"Cornea"},{"key":"5602_CR40","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.ophtha.2003.10.019","volume":"111","author":"Y Matsumoto","year":"2004","unstructured":"Matsumoto Y, Dogru M, Goto E et al (2004) Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 111:1115\u20131120. https:\/\/doi.org\/10.1016\/j.ophtha.2003.10.019","journal-title":"Ophthalmology"},{"key":"5602_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.clae.2007.11.004","volume":"31","author":"JH Park","year":"2008","unstructured":"Park JH, Jeoung JW, Wee WR et al (2008) Clinical efficacy of amniotic membrane transplantation in the treatment of various ocular surface diseases. Contact Lens Anterior Eye J Br Contact Lens Assoc 31:73\u201380. https:\/\/doi.org\/10.1016\/j.clae.2007.11.004","journal-title":"Contact Lens Anterior Eye J Br Contact Lens Assoc"},{"issue":"19","key":"5602_CR42","doi-asserted-by":"publisher","first-page":"31950","DOI":"10.1016\/j.ophtha.2019.08.020","volume":"S0161\u20136420","author":"SC Pflugfelder","year":"2019","unstructured":"Pflugfelder SC, Massaro-Giordano M, Perez VL et al (2019) Topical recombinant human nerve growth factor (cenegermin) for neurotrophic keratopathy: a multicenter randomized vehicle-controlled pivotal trial. Ophthalmology S0161\u20136420(19):31950\u201331955. https:\/\/doi.org\/10.1016\/j.ophtha.2019.08.020","journal-title":"Ophthalmology"},{"key":"5602_CR43","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1136\/bjo.85.12.1455","volume":"85","author":"P Prabhasawat","year":"2001","unstructured":"Prabhasawat P, Tesavibul N, Komolsuradej W (2001) Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation. Br J Ophthalmol 85:1455\u20131463. https:\/\/doi.org\/10.1136\/bjo.85.12.1455","journal-title":"Br J Ophthalmol"},{"key":"5602_CR44","doi-asserted-by":"publisher","unstructured":"K Schuerch A Baeriswyl BE Frueh C Tappeiner 2019 Efficacy of amniotic membrane transplantation for the treatment of corneal ulcers Cornea https:\/\/doi.org\/10.1097\/ICO.0000000000002179.10.1097\/ICO.0000000000002179","DOI":"10.1097\/ICO.0000000000002179.10.1097\/ICO.0000000000002179"},{"key":"5602_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3109\/08820538.2013.768678","volume":"29","author":"E Turkoglu","year":"2014","unstructured":"Turkoglu E, Celik E, Alagoz G (2014) A comparison of the efficacy of autologous serum eye drops with amniotic membrane transplantation in neurotrophic keratitis. Semin Ophthalmol 29:119\u2013126. https:\/\/doi.org\/10.3109\/08820538.2013.768678","journal-title":"Semin Ophthalmol"},{"key":"5602_CR46","doi-asserted-by":"publisher","first-page":"3538764","DOI":"10.1155\/2018\/3538764","volume":"2018","author":"D Wr\u00f3bel-Dudzi\u0144ska","year":"2018","unstructured":"Wr\u00f3bel-Dudzi\u0144ska D, Alio J, Rodriguez A et al (2018) Clinical efficacy of platelet-rich plasma in the treatment of neurotrophic corneal ulcer. J Ophthalmol 2018:3538764\u20133538764. https:\/\/doi.org\/10.1155\/2018\/3538764","journal-title":"J Ophthalmol"},{"key":"5602_CR47","doi-asserted-by":"publisher","unstructured":"Sweeney AR, Wang M, Weller CL, et al (2020) Outcomes of corneal neurotisation using processed nerve allografts: a multicentre case series. Br J Ophthalmol bjophthalmol-2020\u2013317361. https:\/\/doi.org\/10.1136\/bjophthalmol-2020-317361","DOI":"10.1136\/bjophthalmol-2020-317361"},{"key":"5602_CR48","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s10792-017-0582-7","volume":"38","author":"RM Sanchez-Avila","year":"2018","unstructured":"Sanchez-Avila RM, Merayo-Lloves J, Riestra AC et al (2018) Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops. Int Ophthalmol 38:1193\u20131204. https:\/\/doi.org\/10.1007\/s10792-017-0582-7","journal-title":"Int Ophthalmol"},{"key":"5602_CR49","doi-asserted-by":"publisher","unstructured":"LEE S-H, TSENG SCG, 1997 Amniotic membrane transplantation for persistent epithelial defects with ulceration Am J Ophthalmol 123 303 312 https:\/\/doi.org\/10.1016\/S0002-9394(14)70125-4","DOI":"10.1016\/S0002-9394(14)70125-4"},{"key":"5602_CR50","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/IOP.0000000000001181","volume":"35","author":"IM Leyngold","year":"2019","unstructured":"Leyngold IM, Yen MT, Tian J et al (2019) Minimally invasive corneal neurotization with acellular nerve allograft: surgical technique and clinical outcomes. Ophthal Plast Reconstr Surg 35:133\u2013140. https:\/\/doi.org\/10.1097\/IOP.0000000000001181","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"5602_CR51","first-page":"323","volume":"73","author":"MG Alper","year":"1975","unstructured":"Alper MG (1975) The anesthetic eye: an investigation of changes in the anterior ocular segment of the monkey caused by interrupting the trigeminal nerve at various levels along its course. Trans Am Ophthalmol Soc 73:323\u2013365","journal-title":"Trans Am Ophthalmol Soc"},{"key":"5602_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3928\/1081597X-20140120-10","volume":"30","author":"L Chen","year":"2014","unstructured":"Chen L, Wei RH, Tan DTH et al (2014) Nerve growth factor expression and nerve regeneration in monkey corneas after LASIK. J Refract Surg 30:134\u2013139. https:\/\/doi.org\/10.3928\/1081597X-20140120-10","journal-title":"J Refract Surg"},{"key":"5602_CR53","doi-asserted-by":"publisher","first-page":"4695","DOI":"10.1167\/iovs.16-21372","volume":"58","author":"G Di","year":"2017","unstructured":"Di G, Qi X, Zhao X et al (2017) Corneal epithelium-derived neurotrophic factors promote nerve regeneration. Investig Opthalmology Vis Sci 58:4695. https:\/\/doi.org\/10.1167\/iovs.16-21372","journal-title":"Investig Opthalmology Vis Sci"},{"key":"5602_CR54","doi-asserted-by":"publisher","first-page":"6767","DOI":"10.1167\/iovs.16-19747","volume":"57","author":"JH Park","year":"2016","unstructured":"Park JH, Kang S-S, Kim JY, Tchah H (2016) Nerve growth factor attenuates apoptosis and inflammation in the diabetic cornea. Investig Opthalmology Vis Sci 57:6767. https:\/\/doi.org\/10.1167\/iovs.16-19747","journal-title":"Investig Opthalmology Vis Sci"},{"key":"5602_CR55","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","volume":"11","author":"C Baudouin","year":"2013","unstructured":"Baudouin C, Aragona P, Messmer EM et al (2013) Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf 11:246\u2013258. https:\/\/doi.org\/10.1016\/j.jtos.2013.07.003","journal-title":"Ocul Surf"},{"key":"5602_CR56","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jtos.2020.09.007","volume":"19","author":"RE Ruiz-Lozano","year":"2021","unstructured":"Ruiz-Lozano RE, Hernandez-Camarena JC, Loya-Garcia D et al (2021) The molecular basis of neurotrophic keratopathy: diagnostic and therapeutic implications. Rev Ocul Surf 19:224\u2013240. https:\/\/doi.org\/10.1016\/j.jtos.2020.09.007","journal-title":"Rev Ocul Surf"},{"key":"5602_CR57","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/PRS.0b013e3181904d3a","volume":"123","author":"JK Terzis","year":"2009","unstructured":"Terzis JK, Dryer MM, Bodner BI (2009) Corneal neurotization: a novel solution to neurotrophic keratopathy. Plast Reconstr Surg 123:112\u2013120. https:\/\/doi.org\/10.1097\/PRS.0b013e3181904d3a","journal-title":"Plast Reconstr Surg"},{"key":"5602_CR58","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1056\/NEJM199804233381702","volume":"338","author":"A Lambiase","year":"1998","unstructured":"Lambiase A, Rama P, Bonini S et al (1998) Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med 338:1174\u20131180. https:\/\/doi.org\/10.1056\/NEJM199804233381702","journal-title":"N Engl J Med"},{"key":"5602_CR59","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00055735-199908000-00009","volume":"10","author":"A Lambiase","year":"1999","unstructured":"Lambiase A, Rama P, Aloe L, Bonini S (1999) Management of neurotrophic keratopathy. Curr Opin Ophthalmol 10:270\u2013276. https:\/\/doi.org\/10.1097\/00055735-199908000-00009","journal-title":"Curr Opin Ophthalmol"},{"key":"5602_CR60","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1080\/13543784.2019.1677605","volume":"28","author":"D Bremond-Gignac","year":"2019","unstructured":"Bremond-Gignac D, Daruich A, Robert MP, Chiambaretta F (2019) Recent innovations with drugs in clinical trials for neurotrophic keratitis and refractory corneal ulcers. Expert Opin Investig Drugs 28:1013\u20131020. https:\/\/doi.org\/10.1080\/13543784.2019.1677605","journal-title":"Expert Opin Investig Drugs"},{"key":"5602_CR61","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/08820538.2019.1648692","volume":"34","author":"N Wolkow","year":"2019","unstructured":"Wolkow N, Habib LA, Yoon MK, Freitag SK (2019) Corneal neurotization: review of a new surgical approach and its developments. Semin Ophthalmol 34:473\u2013487. https:\/\/doi.org\/10.1080\/08820538.2019.1648692","journal-title":"Semin Ophthalmol"},{"key":"5602_CR62","doi-asserted-by":"publisher","unstructured":"LN Kanu JB Ciolino 2021 Nerve growth factor as an ocular therapy: applications, challenges, and future directions SeminOphthalmol 1\u20138 https:\/\/doi.org\/10.1080\/08820538.2021.1890793","DOI":"10.1080\/08820538.2021.1890793"},{"key":"5602_CR63","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.2147\/OPTH.S185184","volume":"13","author":"H Sheha","year":"2019","unstructured":"Sheha H, Tighe S, Hashem O, Hayashida Y (2019) Update on cenegermin eye drops in the treatment of neurotrophic keratitis. Clin Ophthalmol 13:1973\u20131980. https:\/\/doi.org\/10.2147\/OPTH.S185184","journal-title":"Clin Ophthalmol"},{"key":"5602_CR64","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/ICU.0b013e3283543b61","volume":"23","author":"A Lambiase","year":"2012","unstructured":"Lambiase A, Sacchetti M, Bonini S (2012) Nerve growth factor therapy for corneal disease. Curr Opin Ophthalmol 23:296\u2013302. https:\/\/doi.org\/10.1097\/ICU.0b013e3283543b61","journal-title":"Curr Opin Ophthalmol"},{"key":"5602_CR65","doi-asserted-by":"publisher","unstructured":"AS Ahuja FW Bowden JL Robben 2020 A novel treatment for neurotrophic corneal ulcer using topical cenegermin (OXERVATE\u2122) containing recombinant human nerve growth factor Cureushttps:\/\/doi.org\/10.7759\/cureus.11724","DOI":"10.7759\/cureus.11724"},{"key":"5602_CR66","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/ICU.0000000000000578","volume":"30","author":"M Koaik","year":"2019","unstructured":"Koaik M, Baig K (2019) Corneal neurotization. Curr Opin Ophthalmol 30:292\u2013298. https:\/\/doi.org\/10.1097\/ICU.0000000000000578","journal-title":"Curr Opin Ophthalmol"},{"key":"5602_CR67","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jtos.2021.02.010","volume":"20","author":"CY Liu","year":"2021","unstructured":"Liu CY, Arteaga AC, Fung SE et al (2021) Corneal neurotization for neurotrophic keratopathy: review of surgical techniques and outcomes. Ocul Surf 20:163\u2013172. https:\/\/doi.org\/10.1016\/j.jtos.2021.02.010","journal-title":"Ocul Surf"},{"key":"5602_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ajo.2016.05.010","volume":"168","author":"N Sharma","year":"2016","unstructured":"Sharma N, Singh D, Maharana PK et al (2016) Comparison of amniotic membrane transplantation and umbilical cord serum in acute ocular chemical burns: a randomized controlled trial. Am J Ophthalmol 168:157\u2013163. https:\/\/doi.org\/10.1016\/j.ajo.2016.05.010","journal-title":"Am J Ophthalmol"},{"key":"5602_CR69","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1542-0124(12)70059-9","volume":"2","author":"SCG Tseng","year":"2004","unstructured":"Tseng SCG, Espana EM, Kawakita T et al (2004) How does amniotic membrane work? Ocul Surf 2:177\u2013187. https:\/\/doi.org\/10.1016\/S1542-0124(12)70059-9","journal-title":"Ocul Surf"},{"key":"5602_CR70","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1167\/iovs.10-5888","volume":"52","author":"E Shay","year":"2011","unstructured":"Shay E, He H, Sakurai S, Tseng SCG (2011) Inhibition of angiogenesis by HC\u00b7HA, a complex of hyaluronan and the heavy chain of inter-\u03b1-inhibitor, purified from human amniotic membrane. Investig Opthalmology Vis Sci 52:2669. https:\/\/doi.org\/10.1167\/iovs.10-5888","journal-title":"Investig Opthalmology Vis Sci"},{"key":"5602_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078441","volume":"8","author":"CL Allen","year":"2013","unstructured":"Allen CL, Clare G, Stewart EA et al (2013) Augmented dried versus cryopreserved amniotic membrane as an ocular surface dressing. PLoS ONE 8:e78441. https:\/\/doi.org\/10.1371\/journal.pone.0078441","journal-title":"PLoS ONE"},{"key":"5602_CR72","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1755-3768.2008.01261.x","volume":"87","author":"MT Rodr\u00edguez-Ares","year":"2009","unstructured":"Rodr\u00edguez-Ares MT, L\u00f3pez-Valladares MJ, Touri\u00f1o R et al (2009) Effects of lyophilization on human amniotic membrane. Acta Ophthalmol (Copenh) 87:396\u2013403. https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01261.x","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"5602_CR73","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1167\/iovs.03-0752","volume":"45","author":"T Nakamura","year":"2004","unstructured":"Nakamura T (2004) Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Invest Ophthalmol Vis Sci 45:93\u201399. https:\/\/doi.org\/10.1167\/iovs.03-0752","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5602_CR74","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.2147\/OPTH.S208008","volume":"14","author":"A Walkden","year":"2020","unstructured":"Walkden A (2020) Amniotic Membrane transplantation in ophthalmology: an updated perspective. Clin Ophthalmol Auckl NZ 14:2057\u20132072. https:\/\/doi.org\/10.2147\/OPTH.S208008","journal-title":"Clin Ophthalmol Auckl NZ"},{"key":"5602_CR75","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1167\/iovs.11-7340","volume":"53","author":"V Freire","year":"2012","unstructured":"Freire V, Andollo N, Etxebarria J et al (2012) In vitro effects of three blood derivatives on human corneal epithelial cells. Invest Ophthalmol Vis Sci 53:5571\u20135578. https:\/\/doi.org\/10.1167\/iovs.11-7340","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5602_CR76","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1167\/iovs.11-7302","volume":"52","author":"E Anitua","year":"2011","unstructured":"Anitua E, Sanchez M, Merayo-Lloves J et al (2011) Plasma rich in growth factors (PRGF-Endoret) stimulates proliferation and migration of primary keratocytes and conjunctival fibroblasts and inhibits and reverts TGF-beta1-Induced myodifferentiation. Invest Ophthalmol Vis Sci 52:6066\u20136073. https:\/\/doi.org\/10.1167\/iovs.11-7302","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5602_CR77","doi-asserted-by":"publisher","unstructured":"L. Alio J, Arnalich-Montiel F, E. Rodriguez A, 2012 The role of \u201ceye platelet rich plasma\u201d (E-Prp) for wound healing in ophthalmology Curr Pharm Biotechnol 13 1257 1265 https:\/\/doi.org\/10.2174\/138920112800624355","DOI":"10.2174\/138920112800624355"},{"key":"5602_CR78","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/s0140-6736(98)24024-4","volume":"351","author":"T Chikama","year":"1998","unstructured":"Chikama T, Fukuda K, Morishige N, Nishida T (1998) Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I. Lancet Lond Engl 351:1783\u20131784. https:\/\/doi.org\/10.1016\/s0140-6736(98)24024-4","journal-title":"Lancet Lond Engl"},{"key":"5602_CR79","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/ICO.0b013e3181a81820","volume":"29","author":"S L\u00f3pez-Plandolit","year":"2010","unstructured":"L\u00f3pez-Plandolit S, Morales M-C, Freire V et al (2010) Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea 29:843\u2013848. https:\/\/doi.org\/10.1097\/ICO.0b013e3181a81820","journal-title":"Cornea"},{"key":"5602_CR80","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.ophtha.2006.12.014","volume":"114","author":"K-C Yoon","year":"2007","unstructured":"Yoon K-C, You I-C, Im S-K et al (2007) Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology 114:1637\u20131642. https:\/\/doi.org\/10.1016\/j.ophtha.2006.12.014","journal-title":"Ophthalmology"},{"key":"5602_CR81","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1136\/bjo.87.11.1312","volume":"87","author":"RB Vajpayee","year":"2003","unstructured":"Vajpayee RB (2003) Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol 87:1312\u20131316. https:\/\/doi.org\/10.1136\/bjo.87.11.1312","journal-title":"Br J Ophthalmol"},{"key":"5602_CR82","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3980\/j.issn.2222-3959.2014.05.12","volume":"7","author":"E Erdem","year":"2014","unstructured":"Erdem E, Yagmur M, Harbiyeli I et al (2014) Umbilical cord blood serum therapy for the management of persistent corneal epithelial defects. Int J Ophthalmol 7:807\u2013810. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2014.05.12","journal-title":"Int J Ophthalmol"},{"key":"5602_CR83","doi-asserted-by":"publisher","unstructured":"D Samarkanova S Martin L Bisbe et al 2020 Clinical evaluation of allogeneic eye drops from cord blood platelet lysate Blood TransfusTrasfus Sangue https:\/\/doi.org\/10.2450\/2020.0130-20","DOI":"10.2450\/2020.0130-20"},{"key":"5602_CR84","first-page":"984","volume":"112","author":"N Yamada","year":"2008","unstructured":"Yamada N (2008) Promotion of corneal epithelial wound healing with a tetrapeptide (SSSR) derived from insulin-like growth factor-1. Nippon Ganka Gakkai Zasshi 112:984\u2013993","journal-title":"Nippon Ganka Gakkai Zasshi"},{"issue":"Suppl 11","key":"5602_CR85","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1097\/ICO.0000000000000587","volume":"34","author":"R Yanai","year":"2015","unstructured":"Yanai R, Nishida T, Chikama T-I et al (2015) Potential new modes of treatment of neurotrophic keratopathy. Cornea 34(Suppl 11):S121-127. https:\/\/doi.org\/10.1097\/ICO.0000000000000587","journal-title":"Cornea"},{"key":"5602_CR86","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s10384-007-0480-z","volume":"51","author":"T Nishida","year":"2007","unstructured":"Nishida T, Chikama T-I, Morishige N et al (2007) Persistent epithelial defects due to neurotrophic keratopathy treated with a substance p-derived peptide and insulin-like growth factor 1. Jpn J Ophthalmol 51:442\u2013447. https:\/\/doi.org\/10.1007\/s10384-007-0480-z","journal-title":"Jpn J Ophthalmol"},{"key":"5602_CR87","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1097\/ICO.0000000000001297","volume":"36","author":"AL Wang","year":"2017","unstructured":"Wang AL, Weinlander E, Metcalf BM et al (2017) Use of topical insulin to treat refractory neurotrophic corneal ulcers. Cornea 36:1426\u20131428. https:\/\/doi.org\/10.1097\/ICO.0000000000001297","journal-title":"Cornea"},{"key":"5602_CR88","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1749-6632.2010.05471.x","volume":"1194","author":"SP Dunn","year":"2010","unstructured":"Dunn SP, Heidemann DG, Chow CYC et al (2010) Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4. Ann N Y Acad Sci 1194:199\u2013206. https:\/\/doi.org\/10.1111\/j.1749-6632.2010.05471.x","journal-title":"Ann N Y Acad Sci"},{"key":"5602_CR89","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jfo.2018.05.009","volume":"42","author":"B Cochener","year":"2019","unstructured":"Cochener B, Zagnoli C, Hugny-Larroque C, Derrien S (2019) Healing of resistant corneal neurotrophic ulcers using a matrix regenerating agent. J Fr Ophtalmol 42:159\u2013165. https:\/\/doi.org\/10.1016\/j.jfo.2018.05.009","journal-title":"J Fr Ophtalmol"},{"key":"5602_CR90","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1089\/jop.2017.0010","volume":"33","author":"M Guerra","year":"2017","unstructured":"Guerra M, Marques S, Gil JQ et al (2017) Neurotrophic keratopathy: therapeutic approach using a novel matrix regenerating agent. J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther 33:662\u2013669. https:\/\/doi.org\/10.1089\/jop.2017.0010","journal-title":"J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther"},{"key":"5602_CR91","doi-asserted-by":"crossref","unstructured":"Del Buey M, Casas P, Lanchares E, et al (2016) Efficacy of the tissue regenerating agent (RGTA) in the treatment of neurotrophic corneal ulcers and persistent epithelial defects. Invest Ophthalmol Vis Sci 57:5731\u2010","DOI":"10.1111\/j.1755-3768.2015.0575"},{"key":"5602_CR92","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/ICO.0000000000000759","volume":"35","author":"RPJ Arvola","year":"2016","unstructured":"Arvola RPJ, Robciuc A, Holopainen JM (2016) Matrix regeneration therapy: a case series of corneal neurotrophic ulcers. Cornea 35:451\u2013455. https:\/\/doi.org\/10.1097\/ICO.0000000000000759","journal-title":"Cornea"},{"key":"5602_CR93","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1167\/iovs.12-10476","volume":"53","author":"A Aifa","year":"2012","unstructured":"Aifa A, Gueudry J, Portmann A et al (2012) Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. Invest Ophthalmol Vis Sci 53:8181\u20138185. https:\/\/doi.org\/10.1167\/iovs.12-10476","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5602_CR94","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3980\/j.issn.2222-3959.2014.06.12","volume":"7","author":"Y-Z Sun","year":"2014","unstructured":"Sun Y-Z, Guo L, Zhang F-S (2014) Curative effect assessment of bandage contact lens in neurogenic keratitis. Int J Ophthalmol 7:980\u2013983. https:\/\/doi.org\/10.3980\/j.issn.2222-3959.2014.06.12","journal-title":"Int J Ophthalmol"},{"key":"5602_CR95","unstructured":"Alshami S., Bradley E.A., Nau C.B., Schornack M. (2018) Outcomes of scleral lens therapy in patients with neurotrophic keratopathy at a tertiary referral center. Invest Ophthalmol Vis Sci 59:"},{"key":"5602_CR96","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1167\/iovs.15-17903","volume":"56","author":"CD Remington","year":"2015","unstructured":"Remington CD, Jacobs DS (2015) PROSE treatment for pediatric patients with neurotrophic keratitis. Invest Ophthalmol Vis Sci 56:6076","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5602_CR97","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/ICO.0b013e31825fed01","volume":"32","author":"M Weyns","year":"2013","unstructured":"Weyns M, Koppen C, Tassignon M-J (2013) Scleral contact lenses as an alternative to tarsorrhaphy for the long-term management of combined exposure and neurotrophic keratopathy. Cornea 32:359\u2013361. https:\/\/doi.org\/10.1097\/ICO.0b013e31825fed01","journal-title":"Cornea"},{"key":"5602_CR98","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jtos.2018.01.003","volume":"16","author":"AS Parra","year":"2018","unstructured":"Parra AS, Roth BM, Nguyen TM et al (2018) Assessment of the Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) scleral lens on visual acuity for corneal irregularity and ocular surface disease. Ocul Surf 16:254\u2013258. https:\/\/doi.org\/10.1016\/j.jtos.2018.01.003","journal-title":"Ocul Surf"},{"key":"5602_CR99","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/ICL.0000000000000748","volume":"47","author":"E Witsberger","year":"2021","unstructured":"Witsberger E, Schornack M (2021) Scleral lens use in neurotrophic keratopathy: a review of current concepts and practice. Eye Contact Lens 47:144\u2013148. https:\/\/doi.org\/10.1097\/ICL.0000000000000748","journal-title":"Eye Contact Lens"},{"key":"5602_CR100","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.survophthal.2003.10.004","volume":"49","author":"HS Dua","year":"2004","unstructured":"Dua HS, Gomes JAP, King AJ, Maharajan VS (2004) The amniotic membrane in ophthalmology. Surv Ophthalmol 49:51\u201377. https:\/\/doi.org\/10.1016\/j.survophthal.2003.10.004","journal-title":"Surv Ophthalmol"},{"key":"5602_CR101","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10561-017-9618-5","volume":"18","author":"K Jirsova","year":"2017","unstructured":"Jirsova K, Jones GLA (2017) Amniotic membrane in ophthalmology: properties, preparation, storage and indications for grafting\u2014a review. Cell Tissue Bank 18:193\u2013204. https:\/\/doi.org\/10.1007\/s10561-017-9618-5","journal-title":"Cell Tissue Bank"},{"key":"5602_CR102","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/ICO.0000000000001866","volume":"38","author":"J Liu","year":"2019","unstructured":"Liu J, Li L, Li X (2019) Effectiveness of cryopreserved amniotic membrane transplantation in corneal ulceration: a meta-analysis. Cornea 38:454\u2013462. https:\/\/doi.org\/10.1097\/ICO.0000000000001866","journal-title":"Cornea"},{"key":"5602_CR103","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1097\/00003226-200111000-00002","volume":"20","author":"CB Cosar","year":"2001","unstructured":"Cosar CB, Cohen EJ, Rapuano CJ et al (2001) Tarsorrhaphy: clinical experience from a cornea practice. Cornea 20:787\u2013791. https:\/\/doi.org\/10.1097\/00003226-200111000-00002","journal-title":"Cornea"},{"key":"5602_CR104","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/archopht.1958.00940080900008","volume":"60","author":"T Gundersen","year":"1958","unstructured":"Gundersen T (1958) Conjunctival flaps in the treatment of corneal disease with reference to a new technique of application. AMA Arch Ophthalmol 60:880\u2013888. https:\/\/doi.org\/10.1001\/archopht.1958.00940080900008","journal-title":"AMA Arch Ophthalmol"},{"key":"5602_CR105","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.3892\/etm.2020.8964","volume":"20","author":"M Zemba","year":"2020","unstructured":"Zemba M, Stamate A-C, Tataru CP et al (2020) Conjunctival flap surgery in the management of ocular surface disease (Review). Exp Ther Med 20:3412\u20133416. https:\/\/doi.org\/10.3892\/etm.2020.8964","journal-title":"Exp Ther Med"},{"key":"5602_CR106","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1136\/bjo.2003.027573","volume":"88","author":"JAP Gomes","year":"2004","unstructured":"Gomes JAP (2004) Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br J Ophthalmol 88:821\u2013825. https:\/\/doi.org\/10.1136\/bjo.2003.027573","journal-title":"Br J Ophthalmol"},{"key":"5602_CR107","first-page":"948","volume":"42","author":"G Geerling","year":"2001","unstructured":"Geerling G, Daniels JT, Dart JK et al (2001) Toxicity of natural tear substitutes in a fully defined culture model of human corneal epithelial cells. Invest Ophthalmol Vis Sci 42:948\u2013956","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"5602_CR108","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1177\/112067210701700311","volume":"17","author":"N Jaenen","year":"2007","unstructured":"Jaenen N, Baudouin C, Pouliquen P et al (2007) Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17:341\u2013349. https:\/\/doi.org\/10.1177\/112067210701700311","journal-title":"Eur J Ophthalmol"},{"key":"5602_CR109","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.ajo.2008.10.019","volume":"147","author":"G Martone","year":"2009","unstructured":"Martone G, Frezzotti P, Tosi GM et al (2009) An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology. Am J Ophthalmol 147:725-735.e1. https:\/\/doi.org\/10.1016\/j.ajo.2008.10.019","journal-title":"Am J Ophthalmol"},{"key":"5602_CR110","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/01.ico.0000240084.27663.fd","volume":"25","author":"FW Fraunfelder","year":"2006","unstructured":"Fraunfelder FW (2006) Corneal toxicity from topical ocular and systemic medications. Cornea 25:1133\u20131138. https:\/\/doi.org\/10.1097\/01.ico.0000240084.27663.fd","journal-title":"Cornea"},{"key":"5602_CR111","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2165\/00003495-200161020-00003","volume":"61","author":"PY Robert","year":"2001","unstructured":"Robert PY, Adenis JP (2001) Comparative review of topical ophthalmic antibacterial preparations. Drugs 61:175\u2013185. https:\/\/doi.org\/10.2165\/00003495-200161020-00003","journal-title":"Drugs"},{"key":"5602_CR112","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1001\/archopht.1983.01040020777023","volume":"101","author":"G Petroutsos","year":"1960","unstructured":"Petroutsos G, Guimaraes R, Giraud J (1960) Pouliquen Y (1983) Antibiotics and corneal epithelial wound healing. Arch Ophthalmol Chic Ill 101:1775\u20131778. https:\/\/doi.org\/10.1001\/archopht.1983.01040020777023","journal-title":"Arch Ophthalmol Chic Ill"},{"key":"5602_CR113","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0039-6257(80)90072-7","volume":"25","author":"NL Burstein","year":"1980","unstructured":"Burstein NL (1980) Corneal cytotoxicity of topically applied drugs, vehicles and preservatives. Surv Ophthalmol 25:15\u201330. https:\/\/doi.org\/10.1016\/0039-6257(80)90072-7","journal-title":"Surv Ophthalmol"},{"key":"5602_CR114","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/TCRM.S58242","volume":"10","author":"TY Chou","year":"2014","unstructured":"Chou TY, Hong BY (2014) Ganciclovir ophthalmic gel 0.15% for the treatment of acute herpetic keratitis: background, effectiveness, tolerability, safety, and future applications. Ther Clin Risk Manag 10:665\u2013681. https:\/\/doi.org\/10.2147\/TCRM.S58242","journal-title":"Ther Clin Risk Manag"},{"key":"5602_CR115","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0166-3542(84)90014-7","volume":"4","author":"JH Lass","year":"1984","unstructured":"Lass JH, Langston RH, Foster CS, Pavan-Langston D (1984) Antiviral medications and corneal wound healing. Antiviral Res 4:143\u2013157. https:\/\/doi.org\/10.1016\/0166-3542(84)90014-7","journal-title":"Antiviral Res"},{"key":"5602_CR116","unstructured":"Rosenthal R (1991) Meta-analytic procedures for social research. SAGE Publications, Inc., 2455 Teller Road,\u00a0Thousand Oaks\u00a0California\u00a091320\u00a0United States of America"},{"key":"5602_CR117","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jtos.2018.10.002","volume":"17","author":"A-M Lobo","year":"2019","unstructured":"Lobo A-M, Agelidis AM, Shukla D (2019) Pathogenesis of herpes simplex keratitis: the host cell response and ocular surface sequelae to infection and inflammation. Ocul Surf 17:40\u201349. https:\/\/doi.org\/10.1016\/j.jtos.2018.10.002","journal-title":"Ocul Surf"},{"key":"5602_CR118","first-page":"163","volume":"8","author":"U Vaidyanathan","year":"2019","unstructured":"Vaidyanathan U, Hopping GC, Liu HY et al (2019) Persistent corneal epithelial defects: a review article. Med Hypothesis Discov Innov Ophthalmol J 8:163\u2013176","journal-title":"Med Hypothesis Discov Innov Ophthalmol J"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05602-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T08:08:47Z","timestamp":1646640527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05602-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":118,"alternative-id":["5602"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05602-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"14 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable for a systematic review and meta-analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable for a systematic review and meta-analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"No conflicts of interest: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript. FC is a consultant for Aerie, Alcon, Allergan, Horus Pharma, Santen, and Thea.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}